Original news and analysis on international IP policy
Tatum Anderson, pour Intellectual Property Watch NAIROBI – Le Kenya Medical Research Institute (KEMRI), l’un des instituts de recherche médicale les plus prestigieux du Kenya, a entamé un audit approfondi de ses découvertes afin d’identifier celles qui pourraient être protégées…
Por Tatum Anderson para Intellectual Property Watch NAIROBI- Uno de los centros de investigación más prestigiosos del país, el Instituto de Investigación Médica de Kenya (KEMRI, por sus siglas en inglés Kenya Medical Research Institute), ha iniciado una amplia auditoría…
Par Paul Garwood Le cycle de négociations qui s’ouvre le mois prochain sur le plan des Nations Unies visant à améliorer l’accès aux médicaments pour les plus pauvres s’annonce difficile, les États et les régions étant divisés sur des sujets…
Por Paul Garwood A la ronda de negociaciones que tendrá lugar el próximo mes sobre un plan de las Naciones Unidas para impulsar el acceso a los medicamentos para los pobres del mundo le espera un camino difícil, en el…
By David Cronin for Intellectual Property Watch Canada has become the first country to notify the World Trade Organisation that it has allowed a drugs firm to use an international scheme for manufacturing generic versions of patented medicines introduced four…
By Paul Garwood Next month’s round of negotiations on a United Nations plan to boost access to medicines for the world’s poor are set for a rough ride, with countries and regions split on contentious issues such as intellectual property…
By Paul Garwood Kenyan authorities are probing who in government may have been “compromised” by the pharmaceutical industry to try strip the African country of its right to produce medicines without patent-holder approval, a senior official said Friday. Ahmed Ogwell,…
Por David Cronin para Intellectual Property Watch BRUSELAS – Aumenta la preocupación tanto en Europa como en los países en desarrollo sobre si diversos acuerdos de libre comercio, cuya firma está programada para finales del presente año, contendrán normas demasiado…
By Paul Garwood Intellectual property can help improve public health, but drug research costs must be controlled so patients in poor countries can afford urgently needed medicines, a World Intellectual Property Organization symposium heard Wednesday. The Geneva-staged event, at which…
By Catherine Saez
In order to explore the relationship between intellectual property rights and life science innovations, the World Intellectual Property Organization (WIPO) is organising policy symposia to identify and clarify the intellectual property dimension in the life sciences.
In a world where biotechnology is booming and new technological frontiers are being crossed, new challenges arise such as ethical questions relating to the implication and applications of biological research. Patent agencies, industry and civil society were invited on 4 September to share their thoughts and experience on the use of the intellectual property system in bioethics.
As Antony Taubman, acting director of the WIPO Global IP Issues Division described it, biotechnology is based on living organisms which raises distinct ethical questions.